Blue Horseshoe Stocks: HEAR Review & More

Turtle Beach Corp. HEAR – Review

Our primary focus has always been to find near-term trading opportunities first, assigning longer-term calls a secondary priority. However, we’ve had quite a bit of good fortune this year in identifying stocks that have gone on to have considerable extended runs.

HEAR is one such stock, that we first signaled for observation on April 9th, at which time the stock was trading for as little as 2.76. Over the ensuing nine weeks, we have seen an incredible, near-continuous bull run that has resulted in new highs of 23.20 yesterday. That works out to an increase of 740% over a span of a little over two months!

Being in blue skies, there’s no telling what new highs we might see in HEAR; it’s certainly plausible to believe we may see our total observed gain reach a thousand percent at some point in the near future. At the rate things have been going, it’s certainly not an unreasonable thought.


H&R Block, Inc. HRB – Fresh Idea

We also want to provide a quick update on our bearish options idea from yesterday’s premarket report, the HRB Weekly $26-24 Puts. We formulated this range after noticing the stock getting kicked hard despite posting an earnings beat in the post-market on Tuesday.

HRB did gap down a little too far for the $26′s to see much action, but we had respectable chances to profit off of the other two contracts in the range. The $25 Puts ran from .65-1.05 for a gain of 62%, while the $24′s put up a double-bag performance with a 133% rip from .15-.35.


Galectin Therapeutics, Inc. GALT

We tagged GALT on Tuesday morning after noticing a big surge in activity, and its run has continued nicely over the course of the week.

We’ve now observed a solid 37% bullish move from 5.83-8.00, and will be on the lookout for the possibility of more new highs.


Extended Watchlist:
ENPH, CTRV, CODX, FCEL, ETSY, ONTX, MYSZ

Blue Horseshoe Stocks: SIG Recap, AXON & More

Signet Jewelers Ltd. SIG – Options Idea

After noticing its solid beat on earnings and reassured guidance yesterday morning in the premarket, we selected a range of options ideas for the SIG chain. Post-earnings options calls have become our bread and butter, and SIG provided yet another example of the reason for that.

Our designated observation range was the SIG Weekly $47.50-50 Calls and all but the 49.50′s enjoyed considerable single-session gains for the day.

$47.50 Calls – Range: 3.70-6.30 – Max Gain: 70%
$48 Calls – Range: 3.21-7.12 – Max Gain: 122%
$48.50 Calls – Range: 3.10-6.00 – Max Gain: 94%
$49 Calls – Range: 2.72-6.17 – Max Gain: 127%
$50 Calls – Range: 1.97-5.21 – Max Gain: 164%
___________

Fresh Options Idea:
Five Below, Inc. FIVE Weekly $90-95 Calls


Axovant Sciences, Inc. AXON

We also included a tag of AXON in yesterday morning’s report, and were met with a pretty good chance for a daily profit there as well. We noticed a slew of Form-4 buys come in on Tuesday, and lo and behold, yesterday the company released news of an $840M+ licensing deal for its Parkinson’s gene therapy.

From a morning low of 3.27, the stock reached a high of 4.64, representing a modest, but very respectable 42% move on the day. We’ll be sure to leave it on our radar in the event that a more sustained move is in the cards.


Extended Watchlist:
ONTX, MRTX, ZS, IMMU, CLWT, CLSD, CLRB

Blue Horseshoe Stocks: VTVT New Highs & More

vTv Therapeutics, Inc. VTVT

We’ve been closely tracking VTVT since including it our report on Tuesday morning as a bottom play. As we mentioned yesterday, the timing was essentially perfect. It took off on Tuesday, and yesterday that run persisted just as we suggested it may.

The stock traded in a range from 1.24 to a new high of 2.67 yesterday, representing an intraday move of 115% From Tuesday’s low of .79 the stock has registered a two-day upswing of 238% and has easily been the NASDAQ’s top play of the week.


Onconova Therapeutics, Inc. ONTX

Speaking of bottom plays, we’re always searching for the next heavily oversold stock, and we’ve got a candidate to bring forth today in ONTX. As you can plainly view on the chart snapshot below, the stock has been heavily sold off, and the RSI is definitely giving off that heavily oversold signal.

The last time that happened the stock did mount an appreciable recovery in the ensuing weeks, so we’re going to put ONTX on extended watch.


Extended Watchlist:
AXXA, IMTV, HMNY, AREX, AYTU, IRBT, AVGR

Incoming search terms:

  • 0ZQK
  • 9C7R
  • salmonh3k
  • strongercu7

Blue Horseshoe Stocks: SNAP Rocking & More

Snap, Inc. SNAP

After we signaled our interest in a range of SNAP calls yesterday morming, the stock turned in quite a performance. In fact, SNAP ended up being the top gainer on the NASDAQ for the session.

That activity paved the way for some excellent intraday moves for our designated contracts, the SNAP Weekly $16-17.50 Calls, which all more than

$16 Calls – Range: 1.15-5.00 – Max Gain: 335%
$16.50 Calls – Range: .93-4.38 – Max Gain: 371%
$17 Calls – Range: .50-4.00 – Max Gain: 700%
$17.50 Calls – Range: .45-3.51– Max Gain: 680%

We feel good about a continuation of the same kind of volatility we saw with SNAP yesterday, and will roll up our potential strike prices, and begin to monitor the SNAP Weekly $21-22.50 Calls as we finish out the week.
_______________

Fresh Options Idea:
GrubHub, Inc. GRUB – Weekly $80-85 Calls

Twitter. Inc. TWTR – Weekly $31-33 Calls


Biocept, Inc. BIOC

We want to keep tabs on BIOC after the announcement of a public offering precipitated what we would consider an over-reactionary selloff.

The company raised a sum of roughly $14.8M after offering approximately 32M shares at an exercise price of .45, along with immediately exercise-able warrants to purchase another 32M shares at .50.

We would classify it fall to a new annual low of  .30 yesterday as a kneejerk response, and with the stock being this heavily oversold, we’ll want to put this one on bottom-bounce watch immediately.


Extended Watchlist:
TEUM, SNCR, FOLD, SWN, GCAP, NETE, RIOT, ONTX

Blue Horseshoe Stocks: Options, Bottom-Plays & More

OncoNova Therapeutics, Inc. ONTX

ONTX is hitting the scanner as a premarket gapper this morning, on the heels of a PR announcing a “pivotal” Phase III drug trial. (>>View PR)

The stock’s 1-year analyst price target of $5 doesn’t seem all that far-fetched, especially if ONTX can break past resistance in the channel between 3.00-3.25 as we’ve outlined on the following chart snapshot. Also looking ripe are the RSI which is creeping toward the 50-line, and the MACD in the midst of bullish cross.

We’ll continue to keep an eye on the stock today and into next week.


Tesla Motors, Inc. TSLA – Options Idea

To carry on our recent tradition of presenting weekly options ideas on Friday (which has yielded us some truly epic gains), we have TSLA. Remember, trading weekly contracts so close to expiration carries added risk, so we always need to exercise extra caution when doing so.

The stock is responding well to news that the company’s share offering would be increased to nearly 2.7M shares, or $642.5M. As a result of this increased activity, we’ve identified the range in which the heaviest action is likely to occur in the event of a sustained uptrend.

Our main target area will be TSLA Weekly $242.50-247.50 Calls. We’ll of course begin with the lowest strike price, which is currently in the money, and roll it up from there as needed, depending on how the day’s trading activity unfolds.


Potential Bottom-Play

Pacific Sunwear of California, Inc. PSUN – We also want to quickly make mention of PSUN, which we’ve noticed has come down to new 52-week lows. As our regulars our well aware by now, these sorts of plays have been an area of extreme success lately. Just take a look at the chart to see what we mean. This is a stock that is sorely due for a rebound, and we intend to be watching closely for when that occurs.


Extended Watchlist:
PBMD, AREN, FIT